c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo
Authors:
- Kausik BhattacharyaKBKausik Bhattacharya
- Eileen HsichEHEileen Hsich
- Larry ParkLPLarry Park
- Brian WaltersBWBrian Walters
- Ursula GermannUGUrsula Germann
- Yow-Ming WangYWYow-Ming Wang
- John KyriakisJKJohn Kyriakis
- Ramon MohanlalRMRamon Mohanlal
- Keisuke KuidaKKKeisuke Kuida
- Mark NamchukMNMark Namchuk
- Francesco SalituroFSFrancesco Salituro
- 6 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (1) , 111-118
Abstract
Akt is a central regulator of cardiomyocyte survival after ischemic injury in vitro and in vivo, but the mechanisms regulating Akt activity in the postischemic cardiomyocyte are not known. Furthermore, although much is known about the detrimental role that the c-Jun N-terminal kinases (JNKs) play in promoting death of cells exposed to various stresses, little is known of the molecular mechanisms by which JNK activation can be protective. We report that JNKs are necessary for the reactivation of Akt after ischemic injury. We identified Thr450 of Akt as a residue that is phosphorylated by JNKs, and the phosphorylation status of Thr450 regulates reactivation of Akt after hypoxia, apparently by priming Akt for subsequent phosphorylation by 3-phosphoinositide–dependent protein kinase. The reduction in Akt activity that is induced by JNK inhibition may have significant biological consequences, as we find that JNKs, acting via Akt, are critical determinants of survival in posthypoxic cardiomyocytes in culture. Furthermore, in contrast to selective p38–mitogen-activated protein kinase inhibition, which was cardioprotective in vivo, concurrent inhibition of both JNKs and p38–mitogen-activated protein kinases increased ischemia/reperfusion injury in the heart of the intact rat. These studies demonstrate that reactivation of Akt after resolution of hypoxia and ischemia is regulated by JNKs and suggest that this is likely a central mechanism of the myocyte protective effect of JNKs.Keywords
This publication has 26 references indexed in Scilit:
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Targeted Inhibition of p38 Mitogen-activated Protein Kinase Antagonizes Cardiac Injury and Cell Death Following Ischemia-Reperfusion in VivoJournal of Biological Chemistry, 2004
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Stress protein flux during recovery from simulated ischemia: Induced heat shock protein 70 confers cytoprotection by suppressing JNK activation and inhibiting apoptotic cell deathProteomics, 2003
- Characterization of apoptosis signal transduction pathways in HL‐5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress modelJournal of Cellular Physiology, 2003
- Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase BMolecular and Cellular Biology, 2002
- p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulationCardiovascular Research, 2002
- Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death PathwayScience, 2000
- Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemiaCell Death & Differentiation, 1999
- Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.Journal of Clinical Investigation, 1998